Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 589

2.

Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.

Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.

Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170. Review.

3.

Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.

Peyrot M, Rubin RR.

Diabetes Technol Ther. 2009 Jan;11(1):57-62. doi: 10.1089/dia.2008.0002.

PMID:
19132857
4.

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.

Ann Intern Med. 2012 Sep 4;157(5):336-47. Review.

PMID:
22777524
5.

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.

Roze S, Smith-Palmer J, Valentine WJ, Cook M, Jethwa M, de Portu S, Pickup JC.

J Med Econ. 2016;19(3):236-42. doi: 10.3111/13696998.2015.1113979. Epub 2015 Nov 19.

PMID:
26510389
6.

Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.

Golden SH, Sapir T.

J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. Review.

PMID:
22984955
7.

Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).

Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, Marshall SM, Wood R, Speight J, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JA.

Diabetes Care. 2014 Aug;37(8):2114-22. doi: 10.2337/dc14-0030. Epub 2014 May 22.

PMID:
24854041
8.

An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.

Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Hamblin PS, O'Connell MA, Rodda C, Teede H, O'Neal DN.

Diabetes Technol Ther. 2011 Feb;13(2):105-9. doi: 10.1089/dia.2010.0139.

PMID:
21284476
9.

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.

Hommel E, Olsen B, Battelino T, Conget I, Schütz-Fuhrmann I, Hoogma R, Schierloh U, Sulli N, Gough H, Castañeda J, de Portu S, Bolinder J; SWITCH Study Group.

Acta Diabetol. 2014 Oct;51(5):845-51. doi: 10.1007/s00592-014-0598-7. Epub 2014 Jul 19.

10.

Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.

Moreno-Fernandez J, Gomez FJ, Gazquez M, Pedroche M, García-Manzanares A, Tenias JM, Benito P, Gomez IR.

Diabetes Technol Ther. 2013 Jul;15(7):596-600. doi: 10.1089/dia.2013.0033. Epub 2013 Apr 30.

PMID:
23631604
11.

What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.

Polonsky WH, Hessler D.

Diabetes Technol Ther. 2013 Apr;15(4):295-301. doi: 10.1089/dia.2012.0298. Epub 2013 Feb 21.

PMID:
23427866
12.

Continuous glucose monitoring systems for type 1 diabetes mellitus.

Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2. Review.

PMID:
22258980
13.

Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.

Rodbard D, Jovanovic L, Garg SK.

Diabetes Technol Ther. 2009 Dec;11(12):757-65. doi: 10.1089/dia.2009.0078.

PMID:
20001676
14.

Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.

Olivier P, Lawson ML, Huot C, Richardson C, Nakhla M, Romain J.

J Diabetes Sci Technol. 2014 May;8(3):523-8. doi: 10.1177/1932296814524855. Epub 2014 Feb 27.

15.

Real-time continuous glucose monitoring versus internet-based blood glucose monitoring in adults with type 2 diabetes: a study of treatment satisfaction.

Tang TS, Digby EM, Wright AM, Chan JH, Mazanderani AB, Ross SA, Tildesley HG, Lee AM, White AS, Tildesley HD.

Diabetes Res Clin Pract. 2014 Dec;106(3):481-6. doi: 10.1016/j.diabres.2014.09.050. Epub 2014 Oct 7.

PMID:
25458333
16.

Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.

Roze S, Saunders R, Brandt AS, de Portu S, Papo NL, Jendle J.

Diabet Med. 2015 May;32(5):618-26. doi: 10.1111/dme.12661. Epub 2015 Jan 6.

PMID:
25483869
17.

Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.

Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Farish S, Hamblin PS, O'Connell MA, Rodda C, Rowley K, Teede H, O'Neal DN.

Diabetes Care. 2010 Jun;33(6):1242-8. doi: 10.2337/dc09-1481. Epub 2010 Mar 9. Erratum in: Diabetes Care. 2010 Aug;33(8):1911.

18.

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.

Moreno-Fernandez J, Gómez FJ, Gálvez Moreno MÁ, Castaño JP.

J Diabetes Res. 2016;2016:4171789. doi: 10.1155/2016/4171789. Epub 2016 Nov 29.

19.

Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.

Diabetes Research in Children Network Study Group, Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K.

Pediatr Diabetes. 2009 Apr;10(2):91-6. doi: 10.1111/j.1399-5448.2008.00476.x. Epub 2008 Oct 20.

PMID:
19175899
20.

[Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].

Arranz Martín A, Calle Pascual A, Del Cañizo Gómez FJ, González Albarrán O, Lisbona Gil A, Botella Serrano M, Pallardo Sánchez LF; Grupo de Trabajo de Diabetes de la Sociedad de Endocrinología, Diabetes y Nutrición de Madrid (SENDIMAD).

Endocrinol Nutr. 2015 Apr;62(4):171-9. doi: 10.1016/j.endonu.2015.01.003. Epub 2015 Feb 26. Spanish.

PMID:
25726367

Supplemental Content

Support Center